Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Open accessThe DOI matches its Crossref record; 241 of the 245 references it cites were found in a registry or an index.
Abstract
In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to mesenchymal transition (EMT). The cytoskeleton is an active network of three intracellular filaments: actin cytoskeleton, microtubules, and intermediate filaments. These filaments play a central role in the structural design and cell behavior and are necessary for EMT. During EMT, epithelial cells undergo a cellular transformation as manifested by cell elongation, migration, and invasion, coordinated by actin cytoskeleton reorganization. The actin cytoskeleton is an extremely dynamic structure, controlled by a balance of assembly and disassembly of actin filaments. Actin-binding proteins regulate the process of actin polymerization and depolymerization. Microtubule reorganization also plays an important role in cell migration and polarization. Intermediate filaments are rearranged, switching to a vimentin-rich network, and this protein is used as a marker for a mesenchymal cell. Hence, targeting EMT by regulating the activities of their key components may be a potential solution to metastasis. This review summarizes the research done on the physiological functions of the cytoskeleton, its role in the EMT process, and its effect on multidrug-resistant (MDR) cancer cells-highlight some future perspectives in cancer therapy by targeting cytoskeleton.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A schematic diagram illustrating the resistance mechanisms associated with anti-microtubule drugs. These drugs cross the lipid bilayer of the cell membrane and then bind themselves to β-tubulin to alter the microtubule dynamics, causing mitotic arrest and consequent apoptosis. Drugs can be effluxed before reaching the cellular target with the aid of functional drug transport protein. Disruption in the tubulin/microtubule system can avert anti-microtubule drugs from disrupting the microtubules and leading to drug resistance. Before drug binding occurs, signaling and anti-apoptotic factors may also contribute to drug resistance. MF: microfilaments, Mt: microtubules. [212]. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.](https://figures.cochat.ai/paper-figures/c0e6c310a36f4170b5ceec5f7c0b9936/cytoskeletal-dynamics-in-epithelial-mesenchymal-transition-insights-into-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A critical step in the progression of ovarian cancer metastasis is the epithelial-to-mesenchymal transition (EMT), which is characterized by the loss of E-cadherin, cytoskeletal remodeling and changes in proliferation, motility and apoptosis (Ahmed et al., 2007; Moreno-Bueno et al., 2009; Datta et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Datta et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lahat, G., Zhu, Q.-S., Huang, K.-L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010105 · Cited by 213
RetractedThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 19×
“Epithelial cells are held together by tight junctions (TJs), adherens junctions (AJs), and desmosomes and are also connected to the extracellular matrix (ECM) through integrins [9].”
BackgroundInfluentialMicrotubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000 · cited 1×
“When cells are exiting mitosis, the reverse process, where mitotic spindles resolve and MT network reforms, would result in two functional daughter cells [49,51].”
BackgroundNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · cited 2×
“On the other hand, N-cadherin, fibronectin, vitronectin, and MMPs are transcriptionally upregulated by these three transcription factors, contributing to the mesenchymal phenotypes of the cells [4,10,13,14].”
BackgroundThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
CNS stem cells express a new class of intermediate filament protein
Lendahl, U., Zimmerman, L. B., & McKay, R. D. G. (1990) · Cell · doi:10.1016/0092-8674(90)90662-x · Cited by 3,151
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Guidelines and definitions for research on epithelial-mesenchymal transition
Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., et al. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0237-9 · Cited by 2,226 · cited 1×
“EMT is a reversible process—EMT followed by a MET is crucial for cancer metastasis [15].”
BackgroundMolecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
EMT, the cytoskeleton, and cancer cell invasion
Yilmaz, M., & Christofori, G. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9169-0 · Cited by 1,788 · cited 4×
“Epithelial cells are held together by tight junctions (TJs), adherens junctions (AJs), and desmosomes and are also connected to the extracellular matrix (ECM) through integrins [9].”
BackgroundInfluentialVimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557 · cited 1×
“Vimentin has been shown to be promoting both cell motility and EMT [68].”
BackgroundLoh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315 · cited 1×
“On the other hand, N-cadherin, fibronectin, vitronectin, and MMPs are transcriptionally upregulated by these three transcription factors, contributing to the mesenchymal phenotypes of the cells [4,10,13,14].”
BackgroundSelf-citationEpithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., & Thompson, E. W. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21223 · Cited by 1,091
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071 · cited 1×
“showed in a mouse skin tumor model that the reversion of EMT at the metastatic site via the withdrawal of a Twist1inducing signal was required for the formation of distant metastases [38].”
BackgroundChristiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
Regulation of Actin Filament Assembly by Arp2/3 Complex and Formins
Pollard, T. D. (2007) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.35.040405.101936 · Cited by 1,026 · cited 1×
“The Arp2/3 (actin-related protein2/3) complex is a seven-subunit protein, controlled by its link with the WAVE and WASP family of WH2 domain-containing proteins (WAVE1, 2, & 3, WASP and N-WASP) that bind both the Arp2/3 complex and actin monomers [87,88].”
BackgroundIntegrin-Mediated Activation of Cdc42 Controls Cell Polarity in Migrating Astrocytes through PKCζ
Etienne-Manneville, S., & Hall, A. (2001) · Cell · doi:10.1016/s0092-8674(01)00471-8 · Cited by 1,018
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Adherens junctions: from molecules to morphogenesis
Harris, T. J. C., & Tepass, U. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2927 · Cited by 990 · cited 1×
“E-cadherin complex is destabilized by post-translation modifications, such as increased phosphorylation, internalization and degradation of Ecadherin, and β-catenin [78].”
BackgroundDrees, F., Pokutta, S., Yamada, S., Nelson, W. J., & Weis, W. I. (2005) · Cell · doi:10.1016/j.cell.2005.09.021 · Cited by 985
Ocaña, O. H., Córcoles, R., Fabra, Á., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973 · cited 1×
“In fact, silencing both Prrx and Twist1 simultaneously resulted in increased metastatic foci [39].”
BackgroundThe WASP-WAVE protein network: Connecting the membrane to the cytoskeleton.
Takenawa, T., & Suetsugu, S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2069 · Cited by 947 · cited 1×
“The Arp2/3 (actin-related protein2/3) complex is a seven-subunit protein, controlled by its link with the WAVE and WASP family of WH2 domain-containing proteins (WAVE1, 2, & 3, WASP and N-WASP) that bind both the Arp2/3 complex and actin monomers [87,88].”
BackgroundMendez, M. G., Kojima, S., & Goldman, R. D. (2010) · The FASEB Journal · doi:10.1096/fj.09-151639 · Cited by 939
Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., & Narumiya, S. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26508-1 · Cited by 928
Actin and Actin-Binding Proteins
Pollard, T. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018226 · Cited by 912 · cited 2×
“More than a hundred ABPs fall into seven prominent families, namely actin-monomer-binding proteins, severing proteins, nucleation proteins, actin filament polymerases, capping proteins crosslinking proteins, and filamentbinding proteins [40].”
BackgroundVinculin controls focal adhesion formation by direct interactions with talin and actin
Humphries, J. D., Wang, P., Streuli, C., Geiger, B., Humphries, M. J., & Ballestrem, C. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703036 · Cited by 909
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 863
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
Self-citationNovel functions of vimentin in cell adhesion, migration, and signaling
Ivaska, J., Pallari, H.-M., Nevo, J., & Eriksson, J. E. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.040 · Cited by 785
The actin cytoskeleton and actin-based motility
Svitkina, T. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018267 · Cited by 761 · cited 1×
“It affects the structure and motility of a cell [43], aids in muscle contraction [44], cytokinesis [45], and interacts with myosins to transport vesicles within the cell [46,47].”
BackgroundMarine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739 · cited 2×
“As interactions between integrins and the ECM produce pro-survival signals, a lack of these interactions halts the production of these signals, eventually leading to the onset of anoikis, a form of programmed cell death [28].”
BackgroundMEG3 noncoding RNA: a tumor suppressor
Zhou, Y., Zhang, X., & Klibanski, A. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0008 · Cited by 716
Belmont, L. D., & Mitchison, T. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81037-5 · Cited by 663
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Regulation of cancer cell motility through actin reorganization
Yamazaki, D., Kurisu, S., & Takenawa, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00062.x · Cited by 613 · cited 1×
“Numerous studies have shown that the actin cytoskeleton is reorganized at distinct parts of cells like invadopodia, enabling the movement and migration of cells [59].”
BackgroundMicrotubules and Microtubule-Associated Proteins
Goodson, H. V., & Jonasson, E. M. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022608 · Cited by 579 · cited 3×
“Similar to microfilament, the microtubule is highly dynamic [49], whereby it”
BackgroundP120 Catenin Regulates the Actin Cytoskeleton via Rho Family Gtpases
Noren, N. K., Liu, B. P., Burridge, K., & Kreft, B. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.3.567 · Cited by 576 · cited 1×
“It has also been shown that E-cadherin complexes are attached to the dynamic actin framework via α-catenin and stabilized by suppressing the activity of Rho A and activating Rac and cdc42 [79,80].”
BackgroundThe actin cytoskeleton in cancer cell motility
Olson, M. F., & Sahai, E. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9174-2 · Cited by 572
Movers and shakers: cell cytoskeleton in cancer metastasis
Fife, C. M., McCarroll, J. A., & Kavallaris, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12704 · Cited by 551
Latrunculin alters the actin-monomer subunit interface to prevent polymerization
Morton, W. M., Ayscough, K. R., & McLaughlin, P. J. (2000) · Nature Cell Biology · doi:10.1038/35014075 · Cited by 523
Microtubules in Cell Migration
Etienne-Manneville, S. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155711 · Cited by 508
The cofilin pathway in breast cancer invasion and metastasis
Wang, W., Eddy, R., & Condeelis, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2148 · Cited by 487 · cited 1×
“These family members include the Rho GTPases [60], depolymerization factors the gelsolin family members and ADF family member cofilin [61], actin motor proteins like myosin family members [62], actin nucleation and branching factors Arp2/3 and its regulators [63], and capping proteins like CapG [64].”
BackgroundTropomyosin-Based Regulation of the Actin Cytoskeleton in Time and Space
Gunning, P., O’neill, G., & Hardeman, E. (2008) · Physiological Reviews · doi:10.1152/physrev.00001.2007 · Cited by 478 · cited 1×
“The actin cytoskeleton’s ability to participate in various cellular processes is mainly dependent on its intrinsic dynamic reorganization, which continually happens under the regulation of actin-binding proteins (ABPs) in response to cellular changes [48].”
BackgroundEMT: Mechanisms and therapeutic implications
Singh, M., Yelle, N., Venugopal, C., & Singh, S. K. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.009 · Cited by 475
Molecular diversity of cell-matrix adhesions
Zamir, E., Katz, B.-Z., Aota, S.-I., Yamada, K. M., Geiger, B., & Kam, Z. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.11.1655 · Cited by 458
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Cadherin Engagement Regulates Rho family GTPases
Noren, N. K., Niessen, C. M., Gumbiner, B. M., & Burridge, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100306200 · Cited by 425 · cited 1×
“It has also been shown that E-cadherin complexes are attached to the dynamic actin framework via α-catenin and stabilized by suppressing the activity of Rho A and activating Rac and cdc42 [79,80].”
BackgroundIntermediate Filaments: Structure and Assembly
Herrmann, H., & Aebi, U. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018242 · Cited by 411 · cited 1×
“The intermediate filament protein is characterized by a long, rod-like, α-helical, coiledcoil structure, with both ends flanked by additional residues [52].”
BackgroundRho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Feng, Y., LoGrasso, P. V., Defert, O., & Li, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00683 · Cited by 378
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373 · cited 1×
“Matrixins (MMPs) are actively involved in the invasion—studies have shown that MMP-2 and MMP-9 promote metastatic pathways, such as ECM degradation, cell proliferation, apoptosis, invasion, and morphological changes [29,30].”
BackgroundEarly events in cell adhesion and polarity during epithelial-mesenchymal transition
Huang, R. Y.-J., Guilford, P., & Thiery, J. P. (2012) · Journal of Cell Science · doi:10.1242/jcs.099697 · Cited by 369 · cited 2×
“Separation starts with the sequential loss of TJ, AJ, and desmosome integrity, commencing the transition of epithelial cells into a mesenchymal state [26].”
BackgroundMcConkey, D. J., Choi, W., Marquis, L., Martin, F., Williams, M. B., Shah, J., Svatek, R., Das, A., Adam, L., Kamat, A., et al. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9194-7 · Cited by 368
Targeting EMT in cancer: opportunities for pharmacological intervention
Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.06.006 · Cited by 361
Rho GTPase function in tumorigenesis
Karlsson, R., Pedersen, E. D., Wang, Z., & Brakebusch, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.003 · Cited by 329 · cited 5×
“These family members include the Rho GTPases [60], depolymerization factors the gelsolin family members and ADF family member cofilin [61], actin motor proteins like myosin family members [62], actin nucleation and branching factors Arp2/3 and its regulators [63], and capping proteins like CapG [64].”
BackgroundInfluentialRegulation of microtubules in cell migration
WATANABE, T., NORITAKE, J., & KAIBUCHI, K. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.12.006 · Cited by 326
Targeting autophagy using natural compounds for cancer prevention and therapy
Deng, S., Shanmugam, M. K., Kumar, A. P., Yap, C. T., Sethi, G., & Bishayee, A. (2019) · Cancer · doi:10.1002/cncr.31978 · Cited by 320
Self-citationLIM kinases: function, regulation and association with human disease
Scott, R. W., & Olson, M. F. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0165-6 · Cited by 318
Kim, S., & Coulombe, P. A. (2007) · Genes & Development · doi:10.1101/gad.1552107 · Cited by 316
EMT and Cancer: More Than Meets the Eye
Derynck, R., & Weinberg, R. A. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.026 · Cited by 313 · cited 1×
“actin filaments are arranged in a loosely organized meshwork, often referred to as dendritic networks [20], whereas, in filopodia, actin filaments arrange into parallel bundles [21].”
BackgroundPaclitaxel Resistance in Non–Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations
Monzó, M., Rosell, R., Sánchez, J. J., Lee, J. S., O'Brate, A., González-Larriba, J. L., Alberola, V., Lorenzo, J. C., Núñez, L., Ro, J. Y., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1786 · Cited by 306
Mechanical Properties of the Cytoskeleton and Cells
Pegoraro, A. F., Janmey, P., & Weitz, D. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022038 · Cited by 299
RhoA and microtubule dynamics control cell–basement membrane interaction in EMT during gastrulation
Nakaya, Y., Sukowati, E. W., Wu, Y., & Sheng, G. (2008) · Nature Cell Biology · doi:10.1038/ncb1739 · Cited by 294
The actin cytoskeleton as a sensor and mediator of apoptosis
Desouza, M., Gunning, P. W., & Stehn, J. R. (2012) · BioArchitecture · doi:10.4161/bioa.20975 · Cited by 290
p27Kip1-stathmin interaction influences sarcoma cell migration and invasion
Baldassarre, G., Belletti, B., Nicoloso, M. S., Schiappacassi, M., Vecchione, A., Spessotto, P., Morrione, A., Canzonieri, V., & Colombatti, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.025 · Cited by 277
Regulation of cell migration by dynamic microtubules
Kaverina, I., & Straube, A. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.017 · Cited by 277
Koenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277 · cited 1×
“It has been shown during the EMT process, engagement of integrins by collagen type I results in a loss of E-cadherin mediated cell-cell contact and activation of the β-catenin pathway in pancreatic cells [85].”
BackgroundRoyal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K., & Park, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1709 · Cited by 277
Polytherapy and Targeted Cancer Drug Resistance
Chatterjee, N., & Bivona, T. G. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.003 · Cited by 270
Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells
Shankar, J., Messenberg, A., Chan, J., Underhill, T. M., Foster, L. J., & Nabi, I. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4439 · Cited by 262 · cited 2×
“During the EMT process, filopodia are stabilized through the LIMK/cofilin signaling pathway, suppressing actin fibers’ cleavage [69].”
BackgroundGelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
Chellaiah, M., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D., & Hruska, K. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.665 · Cited by 257 · cited 1×
“It is reported that gelsolin is required to form lamellipodia and podosomes, which are important protrusions for motile cells [97].”
BackgroundOverexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer
Kamai, T., Yamanishi, T., Shirataki, H., Takagi, K., Asami, H., Ito, Y., & Yoshida, K.-I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0436-03 · Cited by 255
Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
Sethi, G., Shanmugam, M., Warrier, S., Merarchi, M., Arfuso, F., Kumar, A., & Bishayee, A. (2018) · Nutrients · doi:10.3390/nu10050645 · Cited by 253
Self-citationThe role of EMT and MET in cancer dissemination
Banyard, J., & Bielenberg, D. R. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1060970 · Cited by 252 · cited 1×
“As histological analyses have revealed that macrometastases exhibit epithelial phenotypes rather than mesenchymal [37], the mesenchymal-to-epithelial transition (MET) theory was proposed to explain this phenomenon.”
BackgroundAssociation of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Kalantari, M., Mohammadinejad, R., Javaheri, T., & Sethi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114002 · Cited by 248
Self-citationGan, Z., Ding, L., Burckhardt, C. J., Lowery, J., Zaritsky, A., Sitterley, K., Mota, A., Costigliola, N., Starker, C. G., Voytas, D. F., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.08.007 · Cited by 241
Sweeney, H. L., & Hammers, D. W. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023200 · Cited by 231 · cited 1×
“It affects the structure and motility of a cell [43], aids in muscle contraction [44], cytokinesis [45], and interacts with myosins to transport vesicles within the cell [46,47].”
BackgroundLong non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
Mishra, S., Verma, S. S., Rai, V., Awasthee, N., Chava, S., Hui, K. M., Kumar, A. P., Challagundla, K. B., Sethi, G., & Gupta, S. C. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03053-0 · Cited by 226
Self-citationJordan, N. V., Johnson, G. L., & Abell, A. N. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17188 · Cited by 220 · cited 1×
“This transition occurs through variable intermediate-hybrid states [77].”
BackgroundActinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer
Honda, K., Yamada, T., Hayashida, Y., Idogawa, M., Sato, S., Hasegawa, F., Ino, Y., Ono, M., & Hirohashi, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.004 · Cited by 218
Sommers, C. L., Heckford, S. E., Skerker, J. M., Worland, P. J., Torri, J. A., Thompson, E. W., Byers, S. W., & Gelmann, E. P. (1992) · PubMed · Cited by 216
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Shanmugam, M. K., Warrier, S., Kumar, A. P., Sethi, G., & Arfuso, F. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170713094319 · Cited by 213 · cited 1×
“EMT also facilitates intravasation by promoting tumor angiogenesis that can promote tumor spread [32,33].”
BackgroundSelf-citationSweeney, H. L., & Holzbaur, E. L. F. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021931 · Cited by 213 · cited 1×
“It affects the structure and motility of a cell [43], aids in muscle contraction [44], cytokinesis [45], and interacts with myosins to transport vesicles within the cell [46,47].”
BackgroundThe Arp2/3 regulatory system and its deregulation in cancer
Molinie, N., & Gautreau, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00006.2017 · Cited by 202 · cited 1×
“These family members include the Rho GTPases [60], depolymerization factors the gelsolin family members and ADF family member cofilin [61], actin motor proteins like myosin family members [62], actin nucleation and branching factors Arp2/3 and its regulators [63], and capping proteins like CapG [64].”
BackgroundPuar, Y., Shanmugam, M., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 197
Self-citationMicrotubules: A dynamic target in cancer therapy
Pasquier, E., & Kavallaris, M. (2008) · IUBMB Life · doi:10.1002/iub.25 · Cited by 195 · cited 1×
“alternates between the states of gradual extension and rapid shortening [50].”
BackgroundBoggs, A. E., Vitolo, M. I., Whipple, R. A., Charpentier, M. S., Goloubeva, O. G., Ioffe, O. B., Tuttle, K. C., Slovic, J., Lu, Y., Mills, G. B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-13-3563 · Cited by 180 · cited 2×
“The acetylation leads to the formation of cell protrusion and tumor cell reattachment, which promote breast cancer metastasis [65].”
BackgroundLi, F., Shanmugam, M. K., Chen, L., Chatterjee, S., Basha, J., Kumar, A. P., Kundu, T. K., & Sethi, G. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0070 · Cited by 180
Self-citationYang, H., Ganguly, A., & Cabral, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160820 · Cited by 178
Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer
Nurwidya, F., Takahashi, F., Murakami, A., & Takahashi, K. (2012) · Cancer Research and Treatment · doi:10.4143/crt.2012.44.3.151 · Cited by 177
Keratins control intercellular adhesion involving PKC-α–mediated desmoplakin phosphorylation
Kröger, C., Loschke, F., Schwarz, N., Windoffer, R., Leube, R. E., & Magin, T. M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201208162 · Cited by 175
Advances in antibody–drug conjugates: A new era of targeted cancer therapy
Sau, S., Alsaab, H. O., Kashaw, S. K., Tatiparti, K., & Iyer, A. K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.011 · Cited by 174
Triple negative breast cancer in Asia: An insider’s view
Wang, C., Kar, S., Lai, X., Cai, W., Arfuso, F., Sethi, G., Lobie, P. E., Goh, B. C., Lim, L. H. K., Hartman, M., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.10.014 · Cited by 174 · cited 1×
“The first step in cancer metastasis is the local invasion of the tissues surrounding the primary tumor [16,17].”
BackgroundSelf-citationShanmugam, M. K., Ahn, K. S., Hsu, A., Woo, C. C., Yuan, Y., Tan, K. H. B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Koh, A. P. F., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01294 · Cited by 174 · cited 1×
“The first step in cancer metastasis is the local invasion of the tissues surrounding the primary tumor [16,17].”
BackgroundSelf-citationInsights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
Cheng, J.-T., Wang, L., Wang, H., Tang, F.-R., Cai, W.-Q., Sethi, G., Xin, H.-W., & Ma, Z. (2019) · Cells · doi:10.3390/cells8101178 · Cited by 172 · cited 1×
“On the other hand, N-cadherin, fibronectin, vitronectin, and MMPs are transcriptionally upregulated by these three transcription factors, contributing to the mesenchymal phenotypes of the cells [4,10,13,14].”
BackgroundSelf-citationLang, S. H., Hyde, C., Reid, I. N., Hitchcock, I. S., Hart, C. A., Gordon Bryden, A. A., Villette, J., Stower, M. J., & Maitland, N. J. (2002) · The Prostate · doi:10.1002/pros.10088 · Cited by 170
A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells
Stehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R. B. B., Sequeira, V. B., Butler, T. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4501 · Cited by 169
Beta and gamma actin mRNAs are differentially located within myoblasts
Hill, M., & Gunning, P. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.825 · Cited by 167
Lee, J. H., Kim, C., Sethi, G., & Ahn, K. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3443 · Cited by 162
Self-citationThe dual role of filamin A in cancer: can't live with (too much of) it, can't live without it
Savoy, R. M., & Ghosh, P. M. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0364 · Cited by 162
Flores Gama, C., Rosales, L. M., Ouellet, G., Dou, Y., Thijssen, S., Usvyat, L., Zhang, H., Kuntsevich, V., Levin, N. W., & Kotanko, P. (2017) · Blood Purification · doi:10.1159/000452731 · Cited by 161
Microtubules and actin crosstalk in cell migration and division
Akhshi, T. K., Wernike, D., & Piekny, A. (2014) · Cytoskeleton · doi:10.1002/cm.21150 · Cited by 160
Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
Huang, J., Li, H., & Ren, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3084 · Cited by 160
Manu, K. A., Shanmugam, M. K., Li, F., Chen, L., Siveen, K. S., Ahn, K. S., Kumar, A. P., & Sethi, G. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1095-0 · Cited by 160
Self-citationManu, K. A., Shanmugam, M. K., Ramachandran, L., Li, F., Siveen, K. S., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Arfuso, F., Kumar, A. P., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.033 · Cited by 159
Self-citationOverview of the Cytoskeleton from an Evolutionary Perspective
Pollard, T. D., & Goldman, R. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030288 · Cited by 159 · cited 2×
“Compared to the other two cytoskeletal components, intermediate filaments are more stable with less fracturing in terms of biochemical properties, with no know motor proteins to travel along [41].”
BackgroundActin-bundling proteins in cancer progression at a glance
Stevenson, R. P., Veltman, D. M., & Machesky, L. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.093799 · Cited by 157
Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression
SUN, B., FANG, Y., LI, Z., CHEN, Z., & XIANG, J. (2015) · Biomedical Reports · doi:10.3892/br.2015.494 · Cited by 154 · cited 1×
“Arp2/3 is frequently overexpressed in malignant tumors, such as breast and liver carcinomas, suggesting a strong correlation between dynamic actin reorganization and cancer progression [89].”
BackgroundIzdebska, M., Zielińska, W., Grzanka, D., & Gagat, M. (2018) · BioMed Research International · doi:10.1155/2018/4578373 · Cited by 154 · cited 1×
“Extensive research has broadened our view on how ABPs affect the rate and extent of polymerization through their wide range of functions—maintaining the pool of monomeric actin (profilin), regulating the state of polymerization of actin filaments (ADF/cofilin), regulating actin filament dynamics and capping (gelsolin,…”
BackgroundHuen, A. C., Park, J. K., Godsel, L. M., Chen, X., Bannon, L. J., Amargo, E. V., Hudson, T. Y., Mongiu, A. K., Leigh, I. M., Kelsell, D. P., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200206098 · Cited by 151 · cited 1×
“Apart from repressing E-cadherin expression, the EMT TFs are also responsible for downregulating the expression of other epithelial genes such as desmoplakin, plakophilin, and plakoglobin [10,26], which are crucial for the formation of desmosomes intercellular junctions that have been reported to work synergistically…”
BackgroundKaramanou, K., Franchi, M., Vynios, D., & Brézillon, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.003 · Cited by 151
Senderowicz, A. M. J., Kaur, G., Sainz, E., Laing, C., Inman, W. D., Rodriguez, J., Crews, P., Malspeis, L., Grever, M. R., Sausville, E. A., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.1.46 · Cited by 150
Whipple, R. A., Matrone, M. A., Cho, E. H., Balzer, E. M., Vitolo, M. I., Yoon, J. R., Ioffe, O. B., Tuttle, K. C., Yang, J., & Martin, S. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4613 · Cited by 150
Absi, A. A., Wurzer, H., Guérin, C. L., Hoffmann, C., Moreau, F., Mao, X., Brown-Clay, J. D., Petrolli, R., Casellas, C. P., Dieterle, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0441 · Cited by 150
The Role of Microtubules and Their Dynamics in Cell Migration
Ganguly, A., Yang, H., Sharma, R., Patel, K. D., & Cabral, F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423905 · Cited by 145
A Hypothesis on the Origin and Evolution of Tubulin
Ludueña, R. F. (2013) · International review of cytology · doi:10.1016/b978-0-12-407699-0.00002-9 · Cited by 141
Odaka, C., Sanders, M. L., & Crews, P. (2000) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.6.947-952.2000 · Cited by 141
Garg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2021) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 139
Self-citationInvolvement of Actin and Actin-Binding Proteins in Carcinogenesis
Izdebska, M., Zielińska, W., Hałas‐Wiśniewska, M., & Grzanka, A. (2020) · Cells · doi:10.3390/cells9102245 · Cited by 138
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors
Juchum, M., Günther, M., & Laufer, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.05.002 · Cited by 134
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
Lee, J. H., Chinnathambi, A., Alharbi, S. A., Shair, O. H. M., Sethi, G., & Ahn, K. S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104504 · Cited by 134
Self-citationShanmugam, M. K., Ong, T. H., Kumar, A. P., Lun, C. K., Ho, P. C., Wong, P. T. H., Hui, K. M., & Sethi, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032476 · Cited by 133
Self-citationDEAD-box helicase DP103 defines metastatic potential of human breast cancers
Shin, E. M., Sin Hay, H., Lee, M. H., Goh, J. N., Tan, T. Z., Sen, Y. P., Lim, S. W., Yousef, E. M., Ong, H. T., Thike, A. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73451 · Cited by 132 · cited 2×
“Filopodia filaments are primarily bundled by small crosslinking actin-binding proteins like fascin [22].”
BackgroundSelf-citationThe Formin Daam1 and Fascin Directly Collaborate to Promote Filopodia Formation
Jaiswal, R., Breitsprecher, D., Collins, A., Corrêa, I. R., Xu, M.-Q., & Goode, B. L. (2013) · Current Biology · doi:10.1016/j.cub.2013.06.013 · Cited by 126
Sossey‐Alaoui, K., Safina, A. F., Li, X., Vaughan, M. M., Hicks, D. G., Bakin, A. V., & Cowell, J. K. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060975 · Cited by 122
Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas
Kikuchi, S., Honda, K., Tsuda, H., Hiraoka, N., Imoto, I., Kosuge, T., Umaki, T., Onozato, K., Shitashige, M., Yamaguchi, U., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0075 · Cited by 120
Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome
Jiang, W. G., Martin, T. A., Lewis-Russell, J. M., Douglas‐Jones, A. G., Ye, L., & Mansel, R. E. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-71 · Cited by 119
Microtubule Alterations and Mutations Induced by Desoxyepothilone B
Verrills, N. M., Flemming, C. L., Liu, M., Ivery, M. T. G., Cobon, G. S., Norris, M. D., Haber, M., & Kavallaris, M. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00141-8 · Cited by 118
LIM kinases: cofilin and beyond
Prunier, C., Prudent, R., Kapur, R., Sadoul, K., & Lafanéchère, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16978 · Cited by 118
Vimentin affects the mobility and invasiveness of prostate cancer cells
Zhao, Y., Yan, Q., Long, X., Chen, X., & Wang, Y. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1478 · Cited by 117
Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review)
Škovierová, H., ⁄, T. ⁄. Z. O., del, J. ⁄. N. S. ⁄., ⁄, E. V., & ⁄, E. H. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3320 · Cited by 116 · cited 1×
“The increased activity of MMPs results in the enzymatic degradation of adherens junctions and ECM fibers, which increases cancer cell motility and helps break through the basement membrane and the invasion of neighboring tissue [31].”
BackgroundSossey‐Alaoui, K., Ranalli, T. A., Li, X., Bakin, A. V., & Cowell, J. K. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.011 · Cited by 115
Targeting ROCK/LIMK/cofilin signaling pathway in cancer
Lee, M., Kundu, J. K., Chae, J., & Shim, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01153-w · Cited by 114
Role of ACTN4 in Tumorigenesis, Metastasis, and EMT
Tentler, D., Lomert, E. V., Novitskaya, K., & Barlev, N. A. (2019) · Cells · doi:10.3390/cells8111427 · Cited by 112
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Ashrafizadeh, M., Hushmandi, K., Hashemi, M., Akbari, M. E., Kubatka, P., Raei, M., Koklesová, L., Shahinozzaman, M., Mohammadinejad, R., Najafi, M., et al. (2020) · Biomolecules · doi:10.3390/biom10081159 · Cited by 112 · cited 1×
“This plays a pivotal role in cell movement, division, membrane organization, and cancer progression, all of which require the coordinated turnover and remodeling of the actin filaments [18].”
BackgroundSelf-citationNon‐muscle myosins in tumor progression, cancer cell invasion, and metastasis
Ouderkirk, J. L., & Krendel, M. (2014) · Cytoskeleton · doi:10.1002/cm.21187 · Cited by 110
Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy
Neophytou, C. M., Kyriakou, T.-C., & Papageorgis, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246158 · Cited by 106 · cited 1×
“After reaching the target tissue parenchyma, the disseminated tumor cells (DTCs) can either go into a state of dormancy where they stop proliferation [36] or go on to form micrometastases that may eventually develop into much larger macrometastases.”
BackgroundHaraguchi, M., Okubo, T., Miyashita, Y., Miyamoto, Y., Hayashi, M., Crotti, T. N., McHugh, K. P., & Ozawa, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801125200 · Cited by 105 · cited 1×
“Snail (transcription factor) induces the expression of αvβ3- integrin, which is localized in the invading front of cancer and enhances cell detachment [84].”
BackgroundIntermediate Filaments and the Regulation of Cell Motility during Regeneration and Wound Healing
Cheng, F., & Eriksson, J. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022046 · Cited by 104
Yamamoto, S., Tsuda, H., Honda, K., Onozato, K., Takano, M., Tamai, S., Imoto, I., Inazawa, J., Yamada, T., & Matsubara, O. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.234 · Cited by 101
Hahm, E., & Singh, S. V. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.026 · Cited by 100
Sossey-Alaoui, K., Li, X., Ranalli, T. A., & Cowell, J. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500503200 · Cited by 100
The Src Substrate Tks5, Podosomes (Invadopodia), and Cancer Cell Invasion
COURTNEIDGE, S. A., AZUCENA, E. F., PASS, I., SEALS, D. F., & TESFAY, L. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.014 · Cited by 99 · cited 1×
“Research has also shown that Tks protein is primarily required in invadopodia formation and invasion activity in various human cancer cells [100].”
BackgroundCAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Westbrook, J. A., Cairns, D. A., Peng, J., Speirs, V., Hanby, A. M., Holen, I., Wood, S. L., Ottewell, P. D., Marshall, H. C., Banks, R. E., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv360 · Cited by 99 · cited 2×
“For example, expression of gelsolin, cofilin, CapZ, and thymosin β10 are altered in ovarian cancer, whereas CapZ, CapG, profilin1, cortactin, gelsolin, N-WASp, and WAVE expression levels are changed in prostate cancer [104].”
BackgroundInvadopodia: The leading force
Sibony-Benyamini, H., & Gil-Henn, H. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.04.001 · Cited by 97 · cited 4×
“It is believed that cells can breach the tissue barrier due to the formation of F-actin protrusions, called invadopodia, that degrade the ECM, thereby enabling cell penetration [34].”
BackgroundInfluentialRhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells
El‐Sibai, M., Pertz, O. C., Pang, H., Yip, S.-C., Lorenz, M., Symons, M. H., Condeelis, J. S., Hahn, K. M., & Backer, J. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.016 · Cited by 97
Myosin-Driven Intracellular Transport
Titus, M. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021972 · Cited by 97 · cited 1×
“It affects the structure and motility of a cell [43], aids in muscle contraction [44], cytokinesis [45], and interacts with myosins to transport vesicles within the cell [46,47].”
BackgroundVerrills, N. M., Walsh, B. J., Cobon, G. S., Hains, P. G., & Kavallaris, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303378200 · Cited by 95
Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis
Matsuda, Y., Naito, Z., Kawahara, K., Nakazawa, N., Korc, M., & Ishiwata, T. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14673 · Cited by 93
Cytokinesis in Metazoa and Fungi
Glotzer, M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022343 · Cited by 93 · cited 1×
“It affects the structure and motility of a cell [43], aids in muscle contraction [44], cytokinesis [45], and interacts with myosins to transport vesicles within the cell [46,47].”
BackgroundAshrafizadeh, M., Ang, H. L., Moghadam, E. R., Mohammadi, S., Zarrin, V., Hushmandi, K., Samarghandian, S., Zarrabi, A., Najafi, M., Mohammadinejad, R., et al. (2020) · Biomolecules · doi:10.3390/biom10071040 · Cited by 91
Self-citationMonisha, J., Roy, N. K., Padmavathi, G., Banik, K., Bordoloi, D., Khwairakpam, A. D., Arfuso, F., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., et al. (2018) · Cancers · doi:10.3390/cancers10070228 · Cited by 90
Self-citationDeng, H., Cao, L., Xiao, L., Song, J., Zhang, Y., Zheng, P., & Zheng, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.042 · Cited by 89
Dai, X., Ahn, K. S., Wang, L. Z., Kim, C., Deivasigamni, A., Arfuso, F., Um, J., Kumar, A. P., Chang, Y., Kumar, D., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0391 · Cited by 88
Self-citationCortactin Scaffolds Arp2/3 and WAVE2 at the Epithelial Zonula Adherens
Han, S. P., Gambin, Y., Gomez, G. A., Verma, S., Giles, N., Michael, M., Wu, S. K., Guo, Z., Johnston, W. A., Sierecki, E., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544478 · Cited by 86 · cited 1×
“The overexpression of cortactin has been identified during metastasis [94,95].”
BackgroundNestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma
NARITA, K., Matsuda, Y., Seike, M., Naito, Z., Gemma, A., & Ishiwata, T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2278 · Cited by 84
Anderson, T. W., Vaughan, A. N., & Cramer, L. P. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0034 · Cited by 80 · cited 1×
“In the assembly and disassembly of the actin cytoskeleton, myosin II is considered to play a central role through its ATP- dependent motor function [70].”
BackgroundStem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer
Su, H.-T., Weng, C.-C., Hsiao, P.-J., Chen, L.-H., Kuo, T.-L., Chen, Y.-W., Kuo, K.-K., & Cheng, K.-H. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0511 · Cited by 80
Zhuo, J., Tan, E. H., Yan, B., Tochhawng, L., Jayapal, M., Koh, S., Tay, H. K., Maciver, S. K., Hooi, S. C., Salto‐Tellez, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043594 · Cited by 80 · cited 1×
“The expression and secretion of urokinase plasminogen activator (uPA), an important protein triggering a cascade to degrade extracellular matrix, is dependent on gelsolin, suggesting the role of gelsolin to enhance invasion [98].”
BackgroundSelf-citationZhitnyak, I. Y., Rubtsova, S. N., Litovka, N. I., & Gloushankova, N. A. (2020) · Cells · doi:10.3390/cells9030578 · Cited by 80 · cited 1×
“Microscopy studies have shown that during early EMT, dynamic changes happen at the cell-cell boundaries, which weaken the AJ and cell-cell adhesion [76], resulting in the destabilization of the cellcell junctions.”
BackgroundMorris, H., & Machesky, L. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.658 · Cited by 79 · cited 1×
“The EMT process is regulated by gene expression, post-translational modification of proteins, and reorganization of the cytoskeleton [73].”
BackgroundA vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers
Bollong, M. J., Pietilä, M., Pearson, A. D., Sarkar, T. R., Ahmad, I., Soundararajan, R., Lyssiotis, C. A., Mani, S. A., Schultz, P. G., & Lairson, L. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716009114 · Cited by 79
Ashrafizadeh, M., Najafi, M., Ang, H. L., Moghadam, E. R., Mahabady, M. K., Zabolian, A., Jafaripour, L., Bejandi, A. K., Hushmandi, K., Saleki, H., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8080264 · Cited by 78 · cited 1×
“The polymerization is associated with the formation of flat, sheet-like membrane protrusions called lamellipodia, or finger-like extensions at the edge of lamellipodia called filopodia [19].”
BackgroundSelf-citationEpithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling
Fröse, J., Chen, M. B., Hebron, K. E., Reinhardt, F., Hajal, C., Zijlstra, A., Kamm, R. D., & Weinberg, R. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.092 · Cited by 76 · cited 1×
“In 2018, podocalyxin (PODXL), a cell surface protein whose expression is upregulated during EMT, was found to be essential for mediating the extravasation process of human breast cancer cells by interacting with actin cytoskeletal linker protein ezrin, thereby causing cytoskeletal rearrangements that promote the trans…”
BackgroundVimentin filaments drive migratory persistence in polyploidal cancer cells
Xuan, B., Ghosh, D., Jiang, J. J., Shao, R., & Dawson, M. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011912117 · Cited by 75
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
Unbekandt, M., Croft, D. R., Crighton, D., Mezna, M., McArthur, D. R., McConnell, P., Schüttelkopf, A. W., Belshaw, S., Pannifer, A., Sime, M., et al. (2014) · Cell Communication and Signaling · doi:10.1186/s12964-014-0054-x · Cited by 72
Zhang, T., Zaal, K. J. M., Sheridan, J. F., Mehta, A., Gundersen, G. G., & Ralston, E. (2009) · Journal of Cell Science · doi:10.1242/jcs.039255 · Cited by 69
Molina, A., Vélot, L., Ghouinem, L., Abdelkarim, M., Bouchet, B. P., Luissint, A., Bouhlel, I. B., Morel, M., Sapharikas, E., Tommaso, A. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3565 · Cited by 69
Byrne, F. L., Yang, L., Phillips, P. A., Hansford, L. M., Fletcher, J. I., Ormandy, C. J., McCarroll, J. A., & Kavallaris, M. (2013) · Oncogene · doi:10.1038/onc.2013.11 · Cited by 68
Shanmugam, M. K., Ahn, K. S., Lee, J. H., Kannaiyan, R., Mustafa, N., Manu, K. A., Siveen, K. S., Sethi, G., Chng, W. J., & Kumar, A. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00365 · Cited by 68
Self-citationSim, W. J., Iyengar, P. V., Lama, D., Lui, S. K. L., Ng, H. C., Haviv-Shapira, L., Domany, E., Kappei, D., Tan, T. Z., Saei, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12241-2 · Cited by 67 · cited 2×
“The entire blood vessel escape process involves attaching the cell to the endothelium, crossing the adhesive endothelium, and then finally establishing a secondary tumor site [33].”
BackgroundSelf-citationβIII-Tubulin Regulates Breast Cancer Metastases to the Brain
Kanojia, D., Morshed, R. A., Zhang, L., Miska, J. M., Qiao, J., Kim, J. W., Pytel, P., Balyasnikova, I. V., Lesniak, M. S., & Ahmed, A. U. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0950 · Cited by 66 · cited 1×
“The role of microtubule in metastasis regulation might be subtype-specific, where α-Tubulin and βIII-tubulin have been linked to metastasis [65,66].”
BackgroundImproving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Verrills, N. M., & Kavallaris, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764706 · Cited by 65
Fu, L., Qin, Y., Xie, D., Chow, H. Y., Ngai, S. M., Kwong, D. L. �., Li, Y., & Guan, X. (2007) · Cancer · doi:10.1002/cncr.23110 · Cited by 65
Helgeson, L. A., Prendergast, J. G., Wagner, A. R., Rodnick-Smith, M., & Nolen, B. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587527 · Cited by 65
Chen, X., Zhang, J., Zhang, Z., Li, H., Cheng, W., & Liu, J. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.05.001 · Cited by 64
Wurzer, H., Hoffmann, C., Absi, A. A., & Thomas, C. (2019) · Cells · doi:10.3390/cells8050463 · Cited by 64
Alternative splice variant of actinin-4 in small cell lung cancer
Honda, K., Yamada, T., Seike, M., Hayashida, Y., Idogawa, M., Kondo, T., Ino, Y., & Hirohashi, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207652 · Cited by 63
Alterations in γ-Actin and Tubulin-Targeted Drug Resistance in Childhood Leukemia
Verrills, N. M., Po’uha, S. T., Liu, M. L. M., Liaw, T. Y. E., Larsen, M. R., Ivery, M. T. G., Marshall, G. M., Gunning, P. W., & Kavallaris, M. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj372 · Cited by 63
Kovac, B., Mäkelä, T. P., & Vallenius, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196986 · Cited by 60
EB1 promotes microtubule dynamics by recruiting Sentin in Drosophila cells
Li, W., Miki, T., Watanabe, T., Kakeno, M., Sugiyama, I., Kaibuchi, K., & Goshima, G. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201101108 · Cited by 59
In VitroGrowth Inhibitory Effects of Cytochalasins and Derivatives in Cancer Cells
Goietsenoven, G. V., Mathieu, V., Andolfi, A., Cimmino, A., Lefranc, F., Robert Kiss, A., & Evidente, A. (2010) · Planta Medica · doi:10.1055/s-0030-1250523 · Cited by 59
New Approaches to Targeting the Actin Cytoskeleton for Chemotherapy
Bonello, T., Stehn, J. R., & Gunning, P. W. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.99 · Cited by 58
Kim, S., Kellner, J. C., Lee, C. H., & Coulombe, P. A. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1301 · Cited by 57
Chen, Q., Jiao, D., Yao, Q., Yan, J., Song, J., Chen, F., Lu, G., & Zhou, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1336 · Cited by 57
Ferro, M., Lucarelli, G. T., Crocetto, F., Dolce, P., Verde, A., Civita, E. L., Zappavigna, S., COBELLI, O. D., Lorenzo, G. D., Facchini, B. A., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103198 · Cited by 54
Gan, Z., Ding, L., Burckhardt, C. J., Lowery, J., Zaritsky, A., Sitterley, K., Mota, A. L., Costigliola, N., Starker, C. G., Voytas, D. F., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.11.011 · Cited by 53
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation
Mardilovich, K., Baugh, M. D., Crighton, D., Kowalczyk, D., Gabrielsen, M., Munro, J., Croft, D. R., Lourenço, F. C., James, D. T., Kalna, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6288 · Cited by 52
Hwang, S. T., Yang, M. H., Kumar, A. P., Sethi, G., & Ahn, K. S. (2020) · Biomolecules · doi:10.3390/biom10101406 · Cited by 52 · cited 2×
“actin filaments are arranged in a loosely organized meshwork, often referred to as dendritic networks [20], whereas, in filopodia, actin filaments arrange into parallel bundles [21].”
BackgroundSelf-citationExpression and regulation of the estrogen receptors in PC-3 human prostate cancer cells
Pisolato, R., Lombardi, A. P. G., Vicente, C. M., Lucas, T. F. G., Lazari, M. F. M., & Porto, C. S. (2015) · Steroids · doi:10.1016/j.steroids.2015.12.021 · Cited by 51
Identification of Cancer-Targeted Tropomyosin Inhibitors and Their Synergy with Microtubule Drugs
Currier, M. A., Stehn, J. R., Swain, A., Chen, D., Hook, J., Eiffe, E., Heaton, A., Brown, D., Nartker, B. A., Eaves, D. W., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0873 · Cited by 51
Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma
Menez, J., Chansac, B. L. M., Dorothée, G., Vergnon, I., Jalil, A., Carlier, M., Chouaïb, S., & Mami‐Chouaib, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207347 · Cited by 50
Stingl, J., Andersen, R. J., & Emerman, J. T. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689969 · Cited by 50
Loo, S. Y., Hirpara, J. L., Pandey, V., Tan, T. Z., Yap, C. T., Lobie, P. E., Thiery, J. P., Goh, B. C., Pervaiz, S., Clement, M., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6524 · Cited by 49
Self-citationBusaranon, K., Phiboonchaiyanan, P. P., Sritularak, B., & Pithi Chanvorachote, B. (2015) · Journal of Natural Medicines · doi:10.1007/s11418-015-0931-7 · Cited by 48
Elevated transgelin/TNS1 expression is a potential biomarker in human colorectal cancer
Zhou, H., Zhang, Y., Wu, L., Xie, W.-R., Li, L., Yu, Y., Chen, Y., Lin, Y., & He, X. (2017) · Oncotarget · doi:10.18632/oncotarget.23275 · Cited by 48
Cited by
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Self-citationSTAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., fathi, N., Rezaei, S., Hejazi, E. S., Kakavand, A., Saebfar, H., Hashemi, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106311 · Cited by 185
Paskeh, M. D. A., Ghadyani, F., Hashemi, M., Abbaspour, A., Zabolian, A., Javanshir, S., Razzazan, M., Mirzaei, S., Entezari, M., Goharrizi, M. A. S. B., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106553 · Cited by 177
Self-citationHashemi, M., Arani, H. Z., Orouei, S., Fallah, S., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113774 · Cited by 166
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
Deng, S., Leong, H. C., Datta, A., Gopal, V., Kumar, A. P., & Yap, C. T. (2022) · Cancers · doi:10.3390/cancers14071652 · Cited by 135
“During the EMT process, the cytoskeleton is restructured under a coordinated regulation of ABPs, MTBPs, and regulators of IFs, to weaken cell-cell attachment and strengthen cell-matrix adhesions that transform cancer cells from the stationary epithelial type into migratory mesenchymal type [47,48].”
BackgroundSelf-citation
Metadata
- Authors
- Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Kumar, Alan Prem
- Yap, Celestial T.
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-04-14
- Volume
- 13
- Issue
- 8
- Pages
- 1882
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8070945
- OpenAlex
- W3156599094
- Cited by
- 184
- References
- 245
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 34 · 2023: 33 · 2022: 30 · 2021: 12
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Medical Research Council (r-185-000-353-213)
- Ministry of Education - Singapore (MOE-T2EP30120-0016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- epithelial-mesenchymal transition, cytoskeleton, actin cytoskeleton, microtubules, intermediate filaments, vimentin, metastasis, cell migration, cell invasion, actin-binding proteins, multidrug resistance, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.